More news
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Dr. Elías Campo receives the 2013 Catalan National Research Award
Susana Kalko explains the importance of bioinformatics in an IDIBAPS Platforms Seminar
Dr. Susana Kalko presented on January 15th an IDIBAPS Platforms Seminar in which she explained the services offered by the Bioinformatics Platform, a1
CD6 is a molecule of the immune system which could improve the treatment of sepsis
Sepsis is a generalized and exacerbated inflammatory reaction caused by a serious infection that could lead to multi-organ failure, shock and often d1
IDIBAPS participates in BioCores@BCN to promote high quality scientific services in the area of Barcelona
Dr. Ramon Trullàs presents the mitochondrial DNA hypothesis of Alzheimer's disease in an In-House IDIBAPS Seminar
Dr. Ramon Trullàs, head of the IDIBAPS Neurobiology Unit, presented in January 9th an In-House IDIBAPS Seminar about what he calls the mitochondrial1
Dr. Pere Ginès receives the German Lucie Bolte Prize
Non-coding DNA implicated in type 2 diabetes
Variations in non-coding sections of the genome might be important contributors to type 2 diabetes risk, according to a new study. DNA sequences that1
Psychiatrists and basic scientists describe a dysregulation of the peripheral endocannabinoid system in first psychotic episodes
The journal Neuropsychopharmacology, from the Nature group, recently published an article that describes a dysregulation of the main components of th1
Cardiac-resynchronization therapy is not useful in patients with systolic heart failure and a narrow QRS
A work published in New England Journal of Medicine demonstrates how Cardiac-resynchronization therapy does not reduce the rate of death or hospitali1